PHARMACY

Allergan's proposed acquisition by AbbVie is expected to close in early 2020.

Faced with increasing competition from national chains, consolidation and declining reimbursements, the number of independent pharmacies has dropped.

Cequa is the first and only FDA approved cyclosporine treatment delivered with nanomicellar, or NCELL technology.

Eli Lilly's Reyvow is a new option for the acute treatment of migraine.

MinuteClinic video visits are now available in 32 states.

The divestiture of Rhofade is a key component of Aclaris’ recently announced strategic plan to refocus resources on the development of its immuno-inflammatory development programs.

SB 159 authorizes pharmacists to prescribe PrEP and PEP to patient without a physician prescription and prohibits insurance companies from requiring patients to obtain prior authorization before using their insurance benefits to obtain PrEP or PEP.

Aspirin and extended-release dipyridamole capsules have a market value of roughly $80 million.

PTCB is introducing advanced Assessment-Based Certificate Programs in two specialty areas: Technician Product Verification and Medication History.

DSN found some of the many pharmacists who do more than asked. Here are their stories.

Pharmacy consultant and industry expert Bruce Kneeland takes a look at an independent PBM business model focused on saving money and improving patient outcomes.

Tecfidera capsules, 120 mg and 240 mg had a market value of approximately $3.7 billion for the 12 months ended in August 2019.